This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institut Gustave Roussy. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Yosra Messai: Innovator in Cancer Treatment Assessment
Introduction
Yosra Messai is a prominent inventor based in Villejuif, France. She has made significant contributions to the field of cancer treatment through her innovative research. Her work focuses on improving patient responses to targeted therapies, particularly in the context of PD-1/PDL-1 targeting drugs.
Latest Patents
Yosra Messai holds a patent for a method that assesses the response of patients to anti-PD-1/PDL-1 drugs. This invention is particularly noteworthy as it utilizes the status of the VHL gene (von Hippel-Lindau) to evaluate treatment efficacy. This advancement has the potential to enhance personalized medicine approaches in oncology.
Career Highlights
Messai is affiliated with the Institut Gustave Roussy, a leading cancer research institution. Her role there allows her to collaborate with other experts in the field and contribute to groundbreaking research. With her dedication and expertise, she has established herself as a key figure in cancer treatment innovation.
Collaborations
Yosra has worked alongside notable colleagues such as Salem Chouaib and Muhammad Zaeem Noman. These collaborations have further enriched her research and expanded the impact of her work in the medical community.
Conclusion
Yosra Messai's contributions to cancer treatment assessment through her innovative patent demonstrate her commitment to improving patient outcomes. Her work is paving the way for advancements in personalized medicine, making her a significant figure in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile